Comparing Levovist-Enhanced Pulse Inversion Harmonic Imaging and Ferumoxides-Enhanced MR Imaging of Hepatic Metastases
- 1 May 2003
- journal article
- research article
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 180 (5) , 1339-1346
- https://doi.org/10.2214/ajr.180.5.1801339
Abstract
OBJECTIVE. The aim of this study was to compare the sensitivity of pulse inversion harmonic digital sonography, unenhanced transabdominal sonography, and ferumoxides-enhanced MR imaging in the depiction of liver metastases. In addition, pulse inversion harmonic digital sonography was performed at different scanning times after Levovist injection to define the best phase for depiction. SUBJECTS AND METHODS. Twenty-six consecutive patients with findings of extrahepatic primary malignancies and liver metastases suspected on transabdominal sonography were examined with both pulse inversion harmonic imaging and ferumoxides-enhanced MR imaging within a 7-day period. Pulse inversion harmonic imaging was performed before and at 20, 100, and 180 sec after a bolus injection of Levovist. MR imaging was performed before and after ferumoxides administration, using breath-hold gradient-recalled echo T1-weighted and turbo spin-echo short tau inversion recovery T2-weighted sequences. Two radiologists independently evaluated image quality, and the number, location, and diameter of lesions scanned using both techniques. Intraoperative sonography or at least 8-month follow-up confirmed the lesions depicted. Analyses included Wilcoxon's signed rank test and Interclass correlation test. RESULTS. Levovist-enhanced pulse inversion harmonic imaging revealed 104 metastases on the first scan after contrast injection, 126 on the second scan, and 118 on the third, compared with 66 on the unenhanced scan. Pulse inversion harmonic digital sonography depicted 90% of lesions shown on ferumoxides-enhanced MR imaging (140 metastases) (p = 0.001). CONCLUSION. Levovist-enhanced pulse inversion harmonic digital sonography is a sensitive technique for depiction of liver metastases. Pulse inversion harmonic digital sonography may have a potential role in imaging patients with possible metastatic involvement of the liver. Further studies are needed to define its place in the workup of these patients. At present, ferumoxides-enhanced MR imaging, being more sensitive, must be performed in all patients in whom pulse inversion harmonic digital sonography is not conclusive or when after pulse inversion harmonic digital sonography, patients remain eligible for surgery.Keywords
This publication has 25 references indexed in Scilit:
- Hepatic Malignancies: Improved Detection with Pulse-Inversion US in Late Phase of Enhancement with SH U 508A—Early ExperienceRadiology, 2000
- Detection of liver metastases with pulse inversion harmonic imaging: Preliminary resultsEuropean Radiology, 1999
- Improved Imaging of Liver Metastases with Stimulated Acoustic Emission in the Late Phase of Enhancement with the US Contrast Agent SH U 508A: Early ExperienceRadiology, 1999
- Intramuscular low flow vascular malformations: treatment by means of direct percutaneous embolizationEuropean Journal of Radiology, 1998
- LIVER-SPECIFIC MR IMAGING CONTRAST AGENTSRadiologic Clinics of North America, 1998
- CT during arterial portographyEuropean Radiology, 1996
- Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US.Radiology, 1995
- Hepatic tumors: detection and characterization at 1-T MR imaging enhanced with AMI-25.Radiology, 1994
- Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imaging.American Journal of Roentgenology, 1991
- Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging.Radiology, 1989